Biblio

Export 11300 results:
Author Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Treatment Outcome
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G., Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial., J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
A. Oulhaj, Jernerén, F., Refsum, H., A Smith, D., and de Jager, C. A., Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 2, pp. 547-57, 2016.
P. S. Aisen, Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., Hendrix, S. B., Grundman, M., Schneider, L. S., Schindler, R. J., Salmon, E., Potter, W. Z., Thomas, R. G., Salmon, D., Donohue, M., Bednar, M. M., Touchon, J., and Vellas, B., Report of the task force on designing clinical trials in early (predementia) AD., Neurology, vol. 76, no. 3, pp. 280-6, 2011.
G. Liu, Weinger, J. G., Lu, Z. - L., Xue, F., and Sadeghpour, S., Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial., J Alzheimers Dis, vol. 49, no. 4, pp. 971-90, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial., J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
G. Sacco, Caillaud, C., Ben Sadoun, G., Robert, P., David, R., and Brisswalter, J., Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 1, pp. 19-25, 2016.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry., J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E., Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial., J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
N. Külzow, A Witte, V., Kerti, L., Grittner, U., Schuchardt, J. Philipp, Hahn, A., and Flöel, A., Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults., J Alzheimers Dis, vol. 51, no. 3, pp. 713-25, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.

Pages